Kala Pharmaceuticals Inc.

NASDAQ: KALA · Real-Time Price · USD
8.24
0.17 (2.11%)
At close: Aug 15, 2025, 10:08 AM

Kala Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-38.51M -42.2M -44.82M -142.6M
Depreciation & Amortization
259K 303K 537K 975K
Stock-Based Compensation
8.39M 7.46M 7.01M 16.09M
Other Working Capital
-1.49M 3.18M -14.28M -1.83M
Other Non-Cash Items
2.26M -2.39M -42.12M 22.51M
Deferred Income Tax
n/a n/a n/a 5.42M
Change in Working Capital
-1.78M 8.89M 491K -10.62M
Operating Cash Flow
-29.38M -27.93M -78.91M -108.23M
Capital Expenditures
-208K -610K -313K -886K
Cash Acquisitions
n/a 47K 62.91M -4.65M
Purchase of Investments
n/a -9.87M -4.99M n/a
Sales Maturities Of Investments
n/a 10M 5M 76.25M
Other Investing Acitivies
n/a n/a 114K 92K
Investing Cash Flow
-208K -429K 62.72M 70.8M
Debt Repayment
-5.04M -10M -40.04M -263K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-42K -2M 301K 1.58M
Financial Cash Flow
29.88M 8.51M -7.94M 42.55M
Net Cash Flow
286K -19.85M -24.13M 5.12M
Free Cash Flow
-29.59M -28.54M -79.22M -109.12M